SPECIAL BULLETIN COVID-19 #215-217 Now Available

The NC Division of Health Benefits (DHB) has recently published new Medicaid Bulletin articles pertaining to COVID-19:

SPECIAL BULLETIN COVID-19 #215: NC Medicaid COVID-19 Omicron Surge Flexibilities

This bulletin provides additional information regarding SPECIAL BULLETIN COVID-19 #210, which outlines many COVID-19 surge response flexibilities enacted by NC Medicaid. Additional Information

SPECIAL BULLETIN COVID-19 #216: Pharmacies Will Cover Oral Tablets (Paxlovid and Molnupiravir)

Effective Jan. 1, 2022, NC Medicaid-enrolled pharmacies may bill for FDA/EUA-approved COVID-19 oral tablets (Paxlovid and/or Molnupiravir) dispensed for use to NC Medicaid beneficiaries in a home setting, with a prescription issued by an NC Medicaid-enrolled provider. More Information

SPECIAL BULLETIN COVID-19 #217: Third Dose of Pfizer-BioN Tech Vaccine for Children Ages 5-11

On Jan. 3, 2022, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for a third dose in the primary series for certain immunocompromised children ages 5 through 11. Read More

Providers are encouraged to review this information. All bulletin articles, including those related to COVID-19, are available on DHB's Medicaid Bulletin webpage.